Review



filmarray multiplex molecular diagnostic system  (BioFire Defense)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    BioFire Defense filmarray multiplex molecular diagnostic system
    Detection of respiratory panel (RP) organisms over time across all sites. Detection of <t>FilmArray</t> RP pathogens in the Trend dataset displayed as stacked area graphs. All data views have the same time period (July 2013 through July 2017). (First data view) Count of each organism. The test utilization rate (TUR) metric (purple line, units are FilmArray RP tests performed) and count of FilmArray RP tests that are negative (white are between pathogen count and TUR) are indicated. The y-axis values are not indicated as this is considered proprietary information. (Second data view) Pathogen detection rates for all organisms. (Third data view) Pathogen detection rates for the subset of organisms that show seasonality (see Results and the legend for the list of organisms). (Fourth data view) Human rhinovirus (HRV) or enterovirus (EV) detection rates. The CDC weighted influenza-like illness (ILI; scaled up tenfold to be visible against the pathogen data) is indicated (black line) in the third and fourth data views. Organisms follow the same color scheme in all panels; the order of organisms in the legend (down then across) matches that of the stacked area graph top to bottom.
    Filmarray Multiplex Molecular Diagnostic System, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/filmarray+multiplex+molecular+diagnostic+system/pmc06054708-6-7-6?v=BioFire+Defense
    Average 90 stars, based on 1 article reviews
    filmarray multiplex molecular diagnostic system - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "Automated Real-Time Collection of Pathogen-Specific Diagnostic Data: Syndromic Infectious Disease Epidemiology"

    Article Title: Automated Real-Time Collection of Pathogen-Specific Diagnostic Data: Syndromic Infectious Disease Epidemiology

    Journal: JMIR Public Health and Surveillance

    doi: 10.2196/publichealth.9876

    Detection of respiratory panel (RP) organisms over time across all sites. Detection of FilmArray RP pathogens in the Trend dataset displayed as stacked area graphs. All data views have the same time period (July 2013 through July 2017). (First data view) Count of each organism. The test utilization rate (TUR) metric (purple line, units are FilmArray RP tests performed) and count of FilmArray RP tests that are negative (white are between pathogen count and TUR) are indicated. The y-axis values are not indicated as this is considered proprietary information. (Second data view) Pathogen detection rates for all organisms. (Third data view) Pathogen detection rates for the subset of organisms that show seasonality (see Results and the legend for the list of organisms). (Fourth data view) Human rhinovirus (HRV) or enterovirus (EV) detection rates. The CDC weighted influenza-like illness (ILI; scaled up tenfold to be visible against the pathogen data) is indicated (black line) in the third and fourth data views. Organisms follow the same color scheme in all panels; the order of organisms in the legend (down then across) matches that of the stacked area graph top to bottom.
    Figure Legend Snippet: Detection of respiratory panel (RP) organisms over time across all sites. Detection of FilmArray RP pathogens in the Trend dataset displayed as stacked area graphs. All data views have the same time period (July 2013 through July 2017). (First data view) Count of each organism. The test utilization rate (TUR) metric (purple line, units are FilmArray RP tests performed) and count of FilmArray RP tests that are negative (white are between pathogen count and TUR) are indicated. The y-axis values are not indicated as this is considered proprietary information. (Second data view) Pathogen detection rates for all organisms. (Third data view) Pathogen detection rates for the subset of organisms that show seasonality (see Results and the legend for the list of organisms). (Fourth data view) Human rhinovirus (HRV) or enterovirus (EV) detection rates. The CDC weighted influenza-like illness (ILI; scaled up tenfold to be visible against the pathogen data) is indicated (black line) in the third and fourth data views. Organisms follow the same color scheme in all panels; the order of organisms in the legend (down then across) matches that of the stacked area graph top to bottom.

    Techniques Used:

    Trend influenza detection rate compared with Centers for Disease and Prevention’s (CDC) influenza activity. Percent of combined FilmArray Flu A (all subtypes) and Flu B detections (blue line) and CDC-reported influenza prevalence (black lines). CDC data are aggregated only from regions with participating Trend sites.
    Figure Legend Snippet: Trend influenza detection rate compared with Centers for Disease and Prevention’s (CDC) influenza activity. Percent of combined FilmArray Flu A (all subtypes) and Flu B detections (blue line) and CDC-reported influenza prevalence (black lines). CDC data are aggregated only from regions with participating Trend sites.

    Techniques Used: Activity Assay



    Similar Products

    filmarray multiplex molecular diagnostic system  (BioFire Defense)
    90
    BioFire Defense filmarray multiplex molecular diagnostic system
    Detection of respiratory panel (RP) organisms over time across all sites. Detection of <t>FilmArray</t> RP pathogens in the Trend dataset displayed as stacked area graphs. All data views have the same time period (July 2013 through July 2017). (First data view) Count of each organism. The test utilization rate (TUR) metric (purple line, units are FilmArray RP tests performed) and count of FilmArray RP tests that are negative (white are between pathogen count and TUR) are indicated. The y-axis values are not indicated as this is considered proprietary information. (Second data view) Pathogen detection rates for all organisms. (Third data view) Pathogen detection rates for the subset of organisms that show seasonality (see Results and the legend for the list of organisms). (Fourth data view) Human rhinovirus (HRV) or enterovirus (EV) detection rates. The CDC weighted influenza-like illness (ILI; scaled up tenfold to be visible against the pathogen data) is indicated (black line) in the third and fourth data views. Organisms follow the same color scheme in all panels; the order of organisms in the legend (down then across) matches that of the stacked area graph top to bottom.
    Filmarray Multiplex Molecular Diagnostic System, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/filmarray+multiplex+molecular+diagnostic+system/pmc06054708-6-7-6?v=BioFire+Defense
    Average 90 stars, based on 1 article reviews
    filmarray multiplex molecular diagnostic system - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Detection of respiratory panel (RP) organisms over time across all sites. Detection of FilmArray RP pathogens in the Trend dataset displayed as stacked area graphs. All data views have the same time period (July 2013 through July 2017). (First data view) Count of each organism. The test utilization rate (TUR) metric (purple line, units are FilmArray RP tests performed) and count of FilmArray RP tests that are negative (white are between pathogen count and TUR) are indicated. The y-axis values are not indicated as this is considered proprietary information. (Second data view) Pathogen detection rates for all organisms. (Third data view) Pathogen detection rates for the subset of organisms that show seasonality (see Results and the legend for the list of organisms). (Fourth data view) Human rhinovirus (HRV) or enterovirus (EV) detection rates. The CDC weighted influenza-like illness (ILI; scaled up tenfold to be visible against the pathogen data) is indicated (black line) in the third and fourth data views. Organisms follow the same color scheme in all panels; the order of organisms in the legend (down then across) matches that of the stacked area graph top to bottom.

    Journal: JMIR Public Health and Surveillance

    Article Title: Automated Real-Time Collection of Pathogen-Specific Diagnostic Data: Syndromic Infectious Disease Epidemiology

    doi: 10.2196/publichealth.9876

    Figure Lengend Snippet: Detection of respiratory panel (RP) organisms over time across all sites. Detection of FilmArray RP pathogens in the Trend dataset displayed as stacked area graphs. All data views have the same time period (July 2013 through July 2017). (First data view) Count of each organism. The test utilization rate (TUR) metric (purple line, units are FilmArray RP tests performed) and count of FilmArray RP tests that are negative (white are between pathogen count and TUR) are indicated. The y-axis values are not indicated as this is considered proprietary information. (Second data view) Pathogen detection rates for all organisms. (Third data view) Pathogen detection rates for the subset of organisms that show seasonality (see Results and the legend for the list of organisms). (Fourth data view) Human rhinovirus (HRV) or enterovirus (EV) detection rates. The CDC weighted influenza-like illness (ILI; scaled up tenfold to be visible against the pathogen data) is indicated (black line) in the third and fourth data views. Organisms follow the same color scheme in all panels; the order of organisms in the legend (down then across) matches that of the stacked area graph top to bottom.

    Article Snippet: Deidentified patient test results from the BioFire FilmArray multiplex molecular diagnostic system are sent directly to a cloud database.

    Techniques:

    Trend influenza detection rate compared with Centers for Disease and Prevention’s (CDC) influenza activity. Percent of combined FilmArray Flu A (all subtypes) and Flu B detections (blue line) and CDC-reported influenza prevalence (black lines). CDC data are aggregated only from regions with participating Trend sites.

    Journal: JMIR Public Health and Surveillance

    Article Title: Automated Real-Time Collection of Pathogen-Specific Diagnostic Data: Syndromic Infectious Disease Epidemiology

    doi: 10.2196/publichealth.9876

    Figure Lengend Snippet: Trend influenza detection rate compared with Centers for Disease and Prevention’s (CDC) influenza activity. Percent of combined FilmArray Flu A (all subtypes) and Flu B detections (blue line) and CDC-reported influenza prevalence (black lines). CDC data are aggregated only from regions with participating Trend sites.

    Article Snippet: Deidentified patient test results from the BioFire FilmArray multiplex molecular diagnostic system are sent directly to a cloud database.

    Techniques: Activity Assay